PGK1 Antibody

What is PGK1 and why is it important in research?

PGK1 (phosphoglycerate kinase 1) is a 417 amino acid protein with a molecular weight of approximately 45 kDa that functions as a key glycolytic enzyme. It catalyzes the conversion of 1,3-diphosphoglycerate to 3-phosphoglycerate, generating one molecule of ATP in the process . Beyond its canonical role in glycolysis, PGK1 has several other functions:

• Acts as a cofactor for polymerase alpha

• Participates in angiogenic processes as a disulfide reductase when secreted by tumor cells

• Plays roles in sperm motility

• Interacts with neural membrane receptors like Enolase-2 (Eno2) to influence neurite outgrowth through P38/Limk1/Cofilin signaling

PGK1 has become an important research target due to its dysregulation in various diseases, particularly cancer, where it contributes to metabolic reprogramming and the Warburg effect .

How should I select between monoclonal and polyclonal PGK1 antibodies?

The choice between monoclonal and polyclonal PGK1 antibodies depends on your specific research needs:

Monoclonal PGK1 Antibodies:

• Provide higher specificity and reproducibility between experiments

• Example: Mouse monoclonal antibody (68035-1-Ig) shows high specificity in Western blot across multiple cell lines including A431, NCCIT, PC-3, LNCaP, HeLa, and Jurkat cells

• Ideal for applications requiring consistent batch-to-batch reproducibility

• Better suited for distinguishing between closely related proteins or specific epitopes

• Example: Clone PAT2F4AT (ANT-604) specifically targets the human PGK1 protein

Polyclonal PGK1 Antibodies:

• Recognize multiple epitopes, potentially increasing detection sensitivity

• Example: Rabbit polyclonal antibody (17811-1-AP) detects PGK1 across human, mouse, and rat samples

• May provide stronger signals due to binding multiple epitopes on the target protein

• Useful when protein conformation or modifications might mask certain epitopes

• Example: CAB14039 polyclonal antibody recognizes a sequence corresponding to amino acids 1-417 of human PGK1

For critical quantitative experiments requiring high reproducibility, monoclonal antibodies are generally preferred. For initial detection or when maximum sensitivity is needed, polyclonal antibodies may be advantageous.

What are the recommended sample preparation techniques for optimal PGK1 detection?

Effective sample preparation is critical for reliable PGK1 detection:

For Western Blotting:

• Use standard cell lysis buffers containing protease inhibitors

• For membrane-associated PGK1, consider membrane fractionation techniques as demonstrated in viral replicase studies

• Ammonium sulfate precipitation can be used to remove small molecules before activity assays

• For detecting extracellular PGK1, concentrate culture supernatants via ultrafiltration

For Immunohistochemistry:

• Formalin-fixed paraffin-embedded (FFPE) tissues are commonly used

• Antigen retrieval is critical - use TE buffer pH 9.0 or alternatively citrate buffer pH 6.0

• Specific protocols have been validated for human liver cancer tissue, mouse kidney tissue, rat kidney tissue, and rat testis tissue

For Immunoprecipitation:

• SW 1990 cells and HeLa cells have been successfully used for PGK1 immunoprecipitation

• Use 0.5-4.0 μg antibody per 1.0-3.0 mg of total protein lysate

For Activity Assays:

• When evaluating PGK1 enzyme activity, use dedicated kits (e.g., phosphoglycerate kinase activity kit ab252890)

• Measure absorbance at 340 nm at 0 min and 60 min intervals

How can PGK1 antibodies be utilized in cancer research?

PGK1 has emerged as a significant target in cancer research, with antibodies enabling several key investigative approaches:

Tumor Metabolism Studies:

• PGK1 antibodies enable investigation of the Warburg effect in cancer cells

• Inhibiting PGK1 with small molecules like NG52 reduces epithelial-mesenchymal transition (EMT) processes and reverses the Warburg effect in ovarian cancer cells

• Western blotting with PGK1 antibodies can quantify changes in glycolytic enzyme expression following treatment interventions

Immune Microenvironment Assessment:

• PGK1 expression correlates with immune infiltration patterns in tumor microenvironments

• Functional analysis using PGK1 antibodies has revealed positive correlations between PGK1 expression and neutrophil infiltration

• SSGSEA and TIMER database analyses can evaluate the impact of PGK1 on immune cell populations

What is the role of PGK1 antibodies in studying autoimmune conditions?

PGK1 antibodies serve dual purposes in autoimmune research - both as research tools and as biomarkers of autoimmune conditions themselves:

Anti-PGK1 Autoantibodies in Disease:

• Anti-PGK1 autoantibodies have been identified in immuno-related pancytopenia (IRP) patients

• ELISA techniques using PGK1 antibodies can screen for anti-PGK1 autoantibodies in untreated IRP patients versus severe aplastic anemia (SAA) patients

• Levels of anti-PGK1 autoantibodies correlate with clinical indicators: negatively with platelet counts and positively with white blood cell counts and circulating immune complexes

Diagnostic Applications:

• Detection of anti-PGK1 antibodies helps differentiate IRP from SAA

• Patients with platelet counts >50×10^9/L show lower percentages of PGK1-Ab positivity

• Monitoring anti-PGK1 antibody levels may help assess treatment efficacy in IRP patients

Mechanistic Research:

• PGK1 antibodies enable investigation of how PGK1 autoimmunity impacts bone marrow function

• Studies have shown decreased levels of complement components C3 and C4, CD34+ IgM positivity, and CD5+ B cells in IRP patients after treatment

How can I optimize Western blot protocols for PGK1 detection?

Optimizing Western blot protocols for PGK1 requires attention to several technical aspects:

Antibody Selection and Dilution:

• PGK1 antibodies show a wide effective dilution range (1:5000-1:50000)

• Start with manufacturer-recommended dilutions and optimize based on signal-to-noise ratio

• For sensitive detection, polyclonal antibodies like 17811-1-AP may provide stronger signals

• For highly specific detection, monoclonal antibodies like 68035-1-Ig offer consistent results

Sample Preparation:

• PGK1 is successfully detected in various cell lines including A431, HepG2, HEK-293, HeLa, PC-12, PC-3, and NIH/3T3 cells

• Tissue samples from mouse and rat liver have shown good PGK1 detection

• Use standard RIPA buffer with protease inhibitors for efficient extraction

Expected Band Size:

• The calculated molecular weight of PGK1 is 45 kDa (417 amino acids)

• The observed molecular weight typically appears at 40-45 kDa on Western blots

• Be aware that post-translational modifications may cause slight variations in migration pattern

Common Issues and Solutions:

• Background: Increase blocking time/concentration and optimize secondary antibody dilution

• Weak signal: Increase protein loading, reduce antibody dilution, or extend exposure time

• Multiple bands: Validate with knockout/knockdown controls as demonstrated in publications

What controls should be included when using PGK1 antibodies?

Proper experimental controls are essential for reliable results with PGK1 antibodies:

Positive Controls:

• Cell lines with confirmed PGK1 expression such as HeLa, A431, HepG2, or PC-3 cells

• Tissue samples from liver (mouse/rat) show reliable PGK1 expression

• Recombinant human PGK1 protein can serve as a pure positive control

Negative Controls:

• PGK1 knockdown/knockout samples are ideal negative controls

• Seven publications have validated PGK1 antibodies using KD/KO approaches

• Primary antibody omission controls should always be included

• Isotype controls (matching the host species and immunoglobulin class of the primary antibody)

Validation Strategies:

• Peptide competition assays to confirm specificity

• Cross-validation with multiple antibodies targeting different PGK1 epitopes

• Correlation of Western blot results with mRNA expression data

• For immunohistochemistry, compare staining patterns with established PGK1 expression patterns in tissues

How can I detect extracellular/secreted PGK1?

Detecting extracellular PGK1 requires specialized approaches:

Sample Collection and Preparation:

• Collect conditioned media from cells grown in serum-free conditions

• Concentrate secreted proteins using ultrafiltration or precipitation methods

• For in vivo detection, collect and process blood serum or plasma samples

• Consider density gradient centrifugation to isolate exosomes which may contain PGK1

Detection Methods:

• Western blotting of concentrated conditioned media

• ELISA assays for quantitative measurement of secreted PGK1

• Proximity ligation assays to detect PGK1 interactions with extracellular proteins

• Immunofluorescence techniques have successfully detected extracellular PGK1 interacting with neural membrane receptors like Enolase-2

Biological Significance:

• Extracellular PGK1 can function as a disulfide reductase in angiogenic processes

• Recombinant PGK1-Flag has been used in pull-down assays to identify membrane interaction partners including TRPC5, Tlr9, and Eno2

• Secreted PGK1 promotes neurite outgrowth through P38/Limk1/Cofilin signaling pathways

What are the best methods for studying PGK1 protein-protein interactions?

Several techniques can effectively investigate PGK1 protein-protein interactions:

Co-Immunoprecipitation (Co-IP):

• Five publications have successfully used PGK1 antibodies for Co-IP applications

• Flag pull-down assays using recombinant Pgk1-Flag produced in Baculovirus expression systems have identified membrane protein interactions

• Silver staining followed by LC-MS/MS analysis can identify novel PGK1 binding partners

Proximity-Based Methods:

• Proximity ligation assays (PLA) provide in situ detection of protein interactions

• FRET/BRET approaches can investigate dynamic interactions in live cells

• BioID or APEX2 proximity labeling can identify broader interaction networks

Validation Approaches:

• Reciprocal Co-IP experiments confirm interactions in both directions

• Domain mapping with truncated constructs identifies specific interaction regions

• Functional assays assess biological relevance of identified interactions

• For example, interactions between extracellular PGK1 and Enolase-2 were validated through multiple complementary approaches

How are PGK1 antibodies being used to study non-canonical functions of PGK1?

Recent research has revealed several non-glycolytic functions of PGK1, with antibodies playing crucial roles in these investigations:

Nuclear Functions and Transcriptional Regulation:

• PGK1 antibodies in immunofluorescence studies have revealed nuclear localization patterns

• Co-IP experiments with PGK1 antibodies can identify interactions with transcription factors

• Chromatin immunoprecipitation (ChIP) approaches can investigate potential DNA-binding activities

Post-Translational Modifications:

• Phospho-specific PGK1 antibodies can detect regulatory modifications

• Western blotting with PGK1 antibodies followed by λ-phosphatase treatment helps identify phosphorylated forms

• The CPTAC database contains information on both total protein and phosphorylated protein expression of PGK1 in lung adenocarcinoma

Extracellular Signaling:

• PGK1 antibodies have helped identify PGK1's interaction with neural membrane protein Enolase-2

• This interaction reduces P38/Limk1/Cofilin signaling, promoting neurite outgrowth

• Flag-tagged recombinant PGK1 pull-down assays followed by LC-MS/MS analysis identified 19 peptides from potential interaction partners

What role do PGK1 antibodies play in developing anti-glycolytic cancer therapies?

PGK1 antibodies are instrumental in developing and validating anti-glycolytic cancer therapies:

Target Validation:

• Immunohistochemistry with PGK1 antibodies confirms elevated expression in tumors

• Western blotting quantifies PGK1 levels before and after therapeutic interventions

• Studies have identified PGK1 as a key target for anti-glycolytic therapy in ovarian cancer

Mechanistic Studies:

• PGK1 antibodies help evaluate how inhibitors like NG52 affect PGK1 enzyme activity

• Phosphoglycerate kinase activity assays combined with Western blotting reveal relationships between protein levels and enzymatic function

• Investigation of downstream effects shows PGK1 inhibition reduces epithelial-mesenchymal transition and reverses the Warburg effect

Therapeutic Response Monitoring:

• Immunohistochemistry with PGK1 antibodies can assess target engagement in tumor samples

• Flow cytometry with PGK1 antibodies evaluates changes in PGK1 expression at the single-cell level

• Combination therapy approaches can be optimized by monitoring PGK1 status alongside other metabolic markers

How should I interpret contradictory results from different PGK1 antibodies?

When facing contradictory results from different PGK1 antibodies, systematic troubleshooting is essential:

Epitope Differences:

• Different antibodies target distinct regions of PGK1

• For example, antibody 102-17123 targets the Central region (amino acids 117-145)

• Conformational changes or post-translational modifications might affect epitope accessibility

• Solution: Use multiple antibodies targeting different epitopes to build a complete picture

Antibody Validation Status:

• Check if antibodies have been validated in your specific application and cell/tissue type

• Review citation records for each antibody (e.g., 17811-1-AP has been cited in 74 publications for Western blot)

• Examine validation data including knockdown/knockout controls

• Solution: Prioritize results from more extensively validated antibodies

Technical Variables:

• Different antibodies may require distinct optimization parameters

• Compare recommended dilutions (e.g., 1:5000-1:50000 for WB with 17811-1-AP vs. 1:100-1:500 for CAB14039)

• Assess fixation methods for immunohistochemistry (TE buffer pH 9.0 or citrate buffer pH 6.0)

• Solution: Optimize protocols for each antibody independently before comparing results

What bioinformatic resources are available for integrating PGK1 antibody data with other omics datasets?

Several bioinformatic resources can help integrate PGK1 antibody data with other omics data types:

Immune Infiltration Resources:

• TISIDB (http://cis.hku.hk/TISIDB/) analyzes correlations between PGK1 and immunomodulators, chemokines, and lymphocytes

• TIMER (https://cistrome.shinyapps.io/timer/) evaluates the impact of immune infiltration on clinical prognosis

• GEPIA2021 (http://gepia2021.cancer-pku.cn/) investigates PGK1 expression effects on different immune cell subtypes

Integrated Analysis Approaches:

• SSGSEA in R quantifies correlations between PGK1 expression and immune infiltration

• Combine antibody-based protein quantification with RNA-seq, methylation, and single-cell data

• GEO database (https://www.ncbi.nlm.nih.gov/geo/) contains multiple datasets (e.g., GSE10245, GSE32863, GSE7670) for validation studies

By leveraging these bioinformatic resources, researchers can place their PGK1 antibody findings within broader molecular contexts, enhancing the biological significance of their observations.